186 related articles for article (PubMed ID: 33639312)
1. Clotrimazole-loaded N-(2-hydroxy)-propyl-3-trimethylammonium, O-palmitoyl chitosan nanoparticles for topical treatment of vulvovaginal candidiasis.
Facchinatto WM; Galante J; Mesquita L; Silva DS; Martins Dos Santos D; Moraes TB; Campana-Filho SP; Colnago LA; Sarmento B; das Neves J
Acta Biomater; 2021 Apr; 125():312-321. PubMed ID: 33639312
[TBL] [Abstract][Full Text] [Related]
2. Chitosan-based sponges containing clotrimazole for the topical management of vulvovaginal candidiasis.
Martins F; Morgado DL; Sarmento B; de Camargo ER; das Neves J
Int J Pharm; 2023 Nov; 647():123508. PubMed ID: 37832705
[TBL] [Abstract][Full Text] [Related]
3. Fluconazole and propolis co-encapsulated in chitosan nanoparticles for the treatment of vulvovaginal candidiasis in a murine model.
da Silva JT; Dantas de Sousa PH; Costa AF; de Menezes LB; Alves SF; Pellegrini F; Amaral AC
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37947253
[TBL] [Abstract][Full Text] [Related]
4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
5. Low intensity ultrasound-mediated drug-loaded nanoparticles intravaginal drug delivery: an effective synergistic therapy scheme for treatment of vulvovaginal candidiasis.
Yang M; Cao Y; Zhang Z; Guo J; Hu C; Wang Z; Du Y
J Nanobiotechnology; 2023 Feb; 21(1):53. PubMed ID: 36782198
[TBL] [Abstract][Full Text] [Related]
6. Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis.
Tapia CV; Hermosilla G; Fortes P; Alburquenque C; Bucarey S; Salinas H; Rodas PI; Díaz MC; Magne F
Mycopathologia; 2017 Apr; 182(3-4):339-347. PubMed ID: 27882525
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
Boikov DA; Locke JB; James KD; Bartizal K; Sobel JD
J Antimicrob Chemother; 2017 May; 72(5):1355-1358. PubMed ID: 28158577
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent.
Soriano-Ruiz JL; Calpena-Capmany AC; Cañadas-Enrich C; Febrer NB; Suñer-Carbó J; Souto EB; Clares-Naveros B
Int J Pharm; 2019 Jan; 554():105-115. PubMed ID: 30395953
[TBL] [Abstract][Full Text] [Related]
9. Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.
Ray A; Ray S; George AT; Swaminathan N
Cochrane Database Syst Rev; 2011 Aug; (8):CD008739. PubMed ID: 21833970
[TBL] [Abstract][Full Text] [Related]
10. Antifungal Activity of Chitosan-Coated Poly(lactic-co-glycolic) Acid Nanoparticles Containing Amphotericin B.
Ludwig DB; de Camargo LEA; Khalil NM; Auler ME; Mainardes RM
Mycopathologia; 2018 Aug; 183(4):659-668. PubMed ID: 29497926
[TBL] [Abstract][Full Text] [Related]
11. Clotrimazole multiple W/O/W emulsion as anticandidal agent: Characterization and evaluation on skin and mucosae.
Soriano-Ruiz JL; Suñer-Carbó J; Calpena-Campmany AC; Bozal-de Febrer N; Halbaut-Bellowa L; Boix-Montañés A; Souto EB; Clares-Naveros B
Colloids Surf B Biointerfaces; 2019 Mar; 175():166-174. PubMed ID: 30530002
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
[TBL] [Abstract][Full Text] [Related]
13. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
[TBL] [Abstract][Full Text] [Related]
14. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vaginal ointment of honey and clotrimazole for treatment of vulvovaginal candidiasis: A random clinical trial.
Banaeian S; Sereshti M; Rafieian M; Farahbod F; Kheiri S
J Mycol Med; 2017 Dec; 27(4):494-500. PubMed ID: 28760590
[TBL] [Abstract][Full Text] [Related]
16. A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action.
Cervi VF; Saccol CP; da Rosa Pinheiro T; Santos RCV; Sari MHM; Cruz L
Drug Deliv Transl Res; 2022 Dec; 12(12):2907-2919. PubMed ID: 35499713
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
18. Topical delivery systems containing clotrimazole for the management of candidiasis: Effect of different excipients and enhanced antifungal activity of nanovesicles.
Usach I; Martínez-Álvarez P; Peris JE
Int J Pharm; 2023 Sep; 644():123287. PubMed ID: 37536641
[TBL] [Abstract][Full Text] [Related]
19. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment.
Woodburn KW; Clemens LE; Jaynes J; Joubert LM; Botha A; Nazik H; Stevens DA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31451496
[TBL] [Abstract][Full Text] [Related]
20. p-Coumaric acid loaded into liquid crystalline systems as a novel strategy to the treatment of vulvovaginal candidiasis.
Ferreira PS; Victorelli FD; Rodero CF; Fortunato GC; Araújo VHS; Fonseca-Santos B; Bauab TM; Van Dijck P; Chorilli M
Int J Pharm; 2021 Jun; 603():120658. PubMed ID: 33964336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
